Transcriptome analysis performed on human pancreatic cancer cells treated with piperlongumine showed significantly enhanced mRNA expression of oxidative-stress-induced growth inhibitor 1, which is the protein directly linked to the NRF2 pathway [111]. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.